Providers should prioritize SGLT2 inhibitors in patients with type 2 diabetes to prevent progression to kidney failure
This data helps clinicians adjust dosages, detect potential side effects, and ensure the patients overall health is improving
New England Journal of Medicine, Dec
Insurance coverage varies and depends on your plan, but because Mounjaro is FDA-approved to treat type 2 diabetes, insurance is more likely to cover some or all of the cost if it's prescribed for that condition, says Shapiro
Thus, orlistat is effective in weight management and poses cardiovascular benefits, yet its gastrointestinal side effects and impact on vitamin absorption necessitate careful consideration
A double-blind study found dark spots improved with glutathione + cystine by 77% in 12 weeks, but these benefits faded after supplementation ended (NIH)